Exelixis Inc (EXEL) Stock Price & News - Google Finance

Get the latest Exelixis Inc (EXEL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

6%
OFF

Exelixis (EXEL) Soars 8.6%: Is Further Upside Left In The Stock?

2 weeks from now

Oct 16, 2024 · Exelixis EXEL shares ended the last trading session 8.6% higher at $28.50. The jump came on an impressive volume with a higher-than-average number of shares changing …

yahoo.com

$42.00
OFF

Exelixis (EXEL) Receives A Buy From Truist Financial

2 weeks from now

1 day ago · In a report released today, Asthika Goonewardene from Truist Financial maintained a Buy rating on Exelixis (EXEL – Research Report), with a price target of $42.00. The …

businessinsider.com

$38
OFF

EXEL - Exelixis Inc Stock Price And Quote - FINVIZ.com

2 weeks from now

Aug 7, 2012 · EXEL - Exelixis Inc - Stock screener for investors and traders, financial visualizations. Home: News: ... Exelixis price target raised to $38 from $34 at RBC Capital ...

finviz.com

3%
OFF

Earnings Estimates Rising For Exelixis (EXEL): Will It Gain?

2 weeks from now

Nov 5, 2024 · Exelixis shares have added 30.3% over the past four weeks, suggesting that investors are betting on its impressive estimate revisions. So, you may consider adding it to …

yahoo.com

$2.16
OFF

Exelixis Sets 2025 Guidance In Line With Estimates (EXEL:NASDAQ)

2 weeks from now

2 days ago · Exelixis (NASDAQ:EXEL) expects $2.165B (consensus estimate: $2.17B) in total revenues for fiscal year 2024, with around ~$1.805B in net product revenues. The oncology …

seekingalpha.com

$20.50
OFF

Exelixis | EXEL Stock Price, Company Overview & News - Forbes

2 weeks from now

In recent trading, shares of Exelixis Inc (NASD: EXEL) have crossed above the average analyst 12-month target price of $20.50, changing hands for $20.57/share. By Dividend Channel …

forbes.com

FAQs about Exelixis Inc (EXEL) Stock Price & News - Google Finance Coupon?

What was Exelixis' stock price on January 1st 2024?

Exelixis' stock was trading at $23.99 on January 1st, 2024. Since then, EXEL shares have increased by 49.3% and is now trading at $35.82. How were Exelixis' earnings last quarter? Exelixis, Inc. (NASDAQ:EXEL) released its quarterly earnings results on Tuesday, October, 29th. ...

What is Exelixis Inc?

EXEL - Exelixis Inc - Stock screener for investors and traders, financial visualizations. ...

Should investors buy Exelixis (Exel)?

Exelixis (EXEL) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts are still raising their earnings estimates for the company. ...

Where can I buy shares of Exelixis?

Shares of EXEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Exelixis own? ...

How much will Exelixis make in 2024?

Exelixis (NASDAQ: EXEL) expects $2.165B (consensus estimate: $2.17B) in total revenues for fiscal year 2024, with around ~$1.805B in net product revenues. The oncology company also set financial guidance for 2025, projecting $2.15B - $2.25B (consensus estimate: $2.19B) in revenues for the year with $1.95B-$2.05B in net product revenues. ...

Are Exelixis insiders buying or selling more stock?

In the past three months, Exelixis insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $11,508,610.00 in company stock. Only 2.85% of the stock of Exelixis is held by insiders. 85.27% of the stock of Exelixis is held by institutions. ...